Document Detail


Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases.
MedLine Citation:
PMID:  8951284     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The licensing of two inactivated hepatitis A vaccines for persons 2 years or older necessitates development of recommendations for pediatric use, as well as a review of the current indications for immune globulin (IG) in hepatitis A prophylaxis. Both vaccines are immunogenic and protective in children and adults. A single dose of vaccine induced antibody in 88% to 96% of subjects by 2 weeks and 97% to 100% by 1 month, and protected against subsequent hepatitis A virus (HAV) disease occurring 21 days after receipt of the dose in a community with endemic hepatitis A infection. However, completion of the full vaccine schedule is recommended to assure high antibody titers and likely long-term protection. The major pediatric indications for vaccine are: (1) travelers to areas with intermediate to high rates of endemic hepatitis A, (2) children living in defined and circumscribed communities with high endemic rates or periodic outbreaks of HAV infection, and (3) patients with chronic liver disease. Immune globulin is recommended for postexposure prophylaxis, as vaccine has not yet been demonstrated to be protective for this purpose. Except for travelers, recommendations for IG use are not changed from those in the current edition of the Red Book, and include contacts of cases in the home, child care centers, and other selected sites.
Authors:
-
Related Documents :
11330654 - Demyelinating disease and hepatitis b vaccination: is there a link?
15964484 - Long-term efficacy of hepatitis b vaccine, booster policy, and impact of hepatitis b vi...
2516014 - A cost-effectiveness analysis of a simple micromethod for hepatitis b screening in hepa...
7852954 - Review: protective efficacy of hepatitis b vaccines in neonates.
22944454 - An asymmetric and slightly dimerized structure for the tetanus toxoid protein used in g...
22822594 - Hpv vaccines and pregnancy: the situation in early 2012.
Publication Detail:
Type:  Guideline; Journal Article; Practice Guideline; Review    
Journal Detail:
Title:  Pediatrics     Volume:  98     ISSN:  0031-4005     ISO Abbreviation:  Pediatrics     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1997-01-03     Completed Date:  1997-01-03     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1207-15     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Hepatitis A / economics,  epidemiology,  prevention & control*
Hepatitis A Vaccines
Humans
Immunization Schedule
Immunoglobulin G / administration & dosage
Pediatrics
Prevalence
Societies, Medical
Viral Hepatitis Vaccines / therapeutic use*
Chemical
Reg. No./Substance:
0/Hepatitis A Vaccines; 0/Immunoglobulin G; 0/Viral Hepatitis Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transition of care provided for adolescents with special health care needs. American Academy of Pedi...
Next Document:  Positioning and sudden infant death syndrome (SIDS): update. American Academy of Pediatrics Task For...